Phenominer Database Results (4 results)

 
 
Table "column sort" updates the order of the bars in the chart.
Strain Phenotype Conditions Study Experiment Name Sex Age # of Animals Value Units SEM SD Method Method Duration Post Insult Type Post Insult Time Value Post Insult Time Unit Method Notes Record ID Study ID
SS-Chr 5BN/Mcwi percentage of study population developing mammary tumors during a period of time 7,12-dimethyltetraphene (DMBA) (65 g/kg) (for 105 days) Adamovic T, et al., Genes Chromosomes Cancer. 2010 Nov;49(11):1035-45 mammary gland integrity trait female 152 days-162 days 13 54.0 % manual palpation method 0 DMBA oral gavage 105 days 200 mg DMBA in 10 ml seame oil 11493 86
SS-Chr 6BN/Mcwi percentage of study population developing mammary tumors during a period of time 7,12-dimethyltetraphene (DMBA) (65 mg/kg) (for 105 days) Adamovic T, et al., Genes Chromosomes Cancer. 2010 Nov;49(11):1035-45 mammary gland integrity trait female 152 days-162 days 20 20.0 % manual palpation method 0 DMBA oral gavage 105 days 200 mg DMBA in 10 ml seame oil 11494 86
SS-Chr 9BN/Mcwi percentage of study population developing mammary tumors during a period of time 7,12-dimethyltetraphene (DMBA) (65 mg/kg) (for 105 days) Adamovic T, et al., Genes Chromosomes Cancer. 2010 Nov;49(11):1035-45 mammary gland integrity trait female 152 days-162 days 40 93.0 % manual palpation method 0 DMBA oral gavage 105 days 200 mg DMBA in 10 ml seame oil 11495 86
SS-Chr 3BN/Mcwi percentage of study population developing mammary tumors during a period of time 7,12-dimethyltetraphene (DMBA) (65 mg/kg) (for 105 days) Adamovic T, et al., Genes Chromosomes Cancer. 2010 Nov;49(11):1035-45 mammary gland integrity trait female 152 days-162 days 14 29.0 % manual palpation method 0 DMBA oral gavage 105 days 200 mg DMBA in 10 ml seame oil 65566 86